Superstring Capital Management LP
- SEC CIK
- 0001931118
- Latest filing
- Aug 14, 2026
Holdings in Q4 2023
Holdings as of Dec 31, 2023, filed Feb 14, 2024. Long positions only.
- Positions
- 30
- No filing for Q3 2023
- Portfolio value
- $140.1M
- No filing for Q3 2023
Superstring Capital Management LP did not file a 13F for Q3 2023, so these holdings cannot be compared with the previous quarter and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| IMGNImmunoGen, Inc. | COM | 598,072 | $17.7M | 12.7% | – | – | History |
| CYTKCytokinetics Inc | COM NEW | 177,603 | $14.8M | 10.6% | – | – | History |
| ETNB89bio, Inc. | COM | 1,021,477 | $11.4M | 8.1% | – | – | History |
| IONSIonis Pharmaceuticals Inc | COM | 189,618 | $9.59M | 6.8% | – | – | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 251,295 | $8.94M | 6.4% | – | – | History |
| PTGXProtagonist Therapeutics, Inc | COM | 379,143 | $8.69M | 6.2% | – | – | History |
| IMVTImmunovant, Inc. | COM | 203,592 | $8.58M | 6.1% | – | – | History |
| BBIOBridgeBio Pharma, Inc. | COM | 206,326 | $8.33M | 5.9% | – | – | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 379,626 | $5.54M | 4.0% | – | – | History |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 462,444 | $5.03M | 3.6% | – | – | History |
| NBIXNeurocrine Biosciences Inc | Stock | 29,346 | $3.87M | 2.8% | – | – | History |
| URGNUroGen Pharma Ltd. | COM | 255,430 | $3.83M | 2.7% | – | – | History |
| SVRASavara Inc | COM | 814,266 | $3.83M | 2.7% | – | – | History |
| ROIVRoivant Sciences Ltd. | SHS | 326,161 | $3.66M | 2.6% | – | – | History |
| LNTHLantheus Holdings, Inc. | Stock | 54,896 | $3.40M | 2.4% | – | – | History |
| FATEFate Therapeutics Inc | COM | 847,823 | $3.17M | 2.3% | – | – | History |
| KROSKeros Therapeutics, Inc. | COM | 74,649 | $2.97M | 2.1% | – | – | History |
| SLRNACELYRIN, Inc. | COM | 356,924 | $2.66M | 1.9% | – | – | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 124,040 | $2.47M | 1.8% | – | – | History |
| NKTXNkarta, Inc. | COM | 347,381 | $2.29M | 1.6% | – | – | History |
| KRYSKrystal Biotech, Inc. | COM | 16,086 | $2.00M | 1.4% | – | – | History |
| QTRXQuanterix Corp | COM | 71,760 | $1.96M | 1.4% | – | – | History |
| AXSMAxsome Therapeutics, Inc. | COM | 16,179 | $1.29M | 0.9% | – | – | History |
| SYSo-Young International Inc. | SPONSORED ADS | 796,059 | $1.00M | 0.7% | – | – | History |
| IMTXImmatics N.V. | SHS | 79,213 | $834.1K | 0.6% | – | – | History |
| ALLOAllogene Therapeutics, Inc. | COM | 222,112 | $713.0K | 0.5% | – | – | History |
| INZYInozyme Pharma, Inc. | COM | 123,944 | $528.0K | 0.4% | – | – | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 45,801 | $440.1K | 0.3% | – | – | History |
| SPRBSpruce Biosciences, Inc. | COM | 118,814 | $348.1K | 0.2% | – | – | History |
| Ys Biopharma Co LtdG9845F109 | ORDINARY SHARES | 307,920 | $165.7K | 0.1% | – | – | – |